MACKENZIE FINANCIAL CORP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 410 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$773,828
+83.2%
14,779
+42.3%
0.00%0.0%
Q1 2024$422,502
+11.8%
10,386
+1.6%
0.00%0.0%
Q4 2023$377,842
-1.8%
10,2230.0%0.00%0.0%
Q3 2023$384,896
+2.1%
10,2230.0%0.00%0.0%
Q2 2023$377,024
-22.5%
10,223
-19.8%
0.00%0.0%
Q1 2023$486,655
-35.9%
12,743
-4.5%
0.00%0.0%
Q4 2022$759,559
+69.2%
13,349
+17.5%
0.00%0.0%
Q3 2022$449,000
-83.6%
11,362
-81.7%
0.00%
-75.0%
Q2 2022$2,739,000
-10.6%
62,256
-19.0%
0.00%0.0%
Q1 2022$3,065,000
-5.4%
76,860
-4.6%
0.00%0.0%
Q4 2021$3,240,000
-1.8%
80,579
-0.6%
0.00%
-20.0%
Q3 2021$3,299,000
+174.7%
81,089
+206.7%
0.01%
+150.0%
Q2 2021$1,201,000
+33.0%
26,437
+22.0%
0.00%
+100.0%
Q1 2021$903,000
+100.7%
21,667
+26.6%
0.00%0.0%
Q3 2020$450,000
-39.9%
17,120
-38.7%
0.00%
-50.0%
Q2 2020$749,000
-0.9%
27,942
-33.5%
0.00%0.0%
Q1 2020$756,000
+261.7%
42,018
+255.8%
0.00%
+100.0%
Q4 2019$209,000
-27.7%
11,810
-29.8%
0.00%0.0%
Q2 2019$289,000
+6.6%
16,8200.0%0.00%0.0%
Q1 2019$271,00016,8200.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Third Security, LLC 19,816,162$195,784,0009.33%
BB BIOTECH AG 5,846,564$57,764,0002.74%
QVT Financial LP 4,556,090$45,014,0002.44%
Parametrica Management Ltd 29,578$292,0002.21%
SECTORAL ASSET MANAGEMENT INC 4,389,682$43,370,0001.84%
Belmont Global Advisors, Inc. 257,000$2,539,0001.83%
HARVEY CAPITAL MANAGEMENT INC 394,550$3,898,0001.40%
Lombard Odier Asset Management (USA) Corp 1,350,000$13,338,0000.70%
IRIDIAN ASSET MANAGEMENT LLC/CT 6,199,685$61,253,0000.63%
Callan Capital, LLC 199,230$1,968,0000.53%
View complete list of HALOZYME THERAPEUTICS INC shareholders